Hematologic Malignancy
Childhood Acute Leukemia
CI-CAN-00002184Explore in graph →
PediatricHematologic77 active trials13 evidence items
- NCIt
- C187056
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00002184Explore in graph →
Clinical trials
462 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (40)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06410833 | Belimumab After Rituximab in Resistant Primary Juvenile SS(BRRPJS) | recruiting | Phase 4 | 15 | Peking Union Medical College HospitalOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05682131 | South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol(SCCCG-R-ALL) | recruiting | Phase 4 | 210 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 |
| Jan 12, 2023 |
| clinicaltrials |
Data updated 22 days agoSource updated May 16, 2024source: clinicaltrials